Ruth Du Moulin

Ruth Du Moulin is the current Vice President of Medical Affairs at FORMA Therapeutics. Ruth has been in this position since May of 2020. Prior to this, they served as the Vice President of Medical Affairs and Head of Global Oncology Medical Communications at Takeda Oncology from February of 2017 to May of 2020. Ruth Du Moulin has also held the position of Vice President of Medical Affairs at ARIAD Pharmaceuticals, Inc. from April of 2010 to February of 2017. Ruth was also the Head of Medical Communications at Quanticate from January of 2008 to March of 2010 and the Head of Clinical Programming and Writing at Pfizer from January of 2004 to January of 2008. Ruth Du Moulin began their career as a Senior Scientific Communications Associate at Eli Lilly from May of 2002 to December of 2003. Ruth then served as a Postdoctoral Researcher at The Heart Research Institute from January of 2000 to December of 2002.

Ruth Du Moulin has a PhD from National University of Ireland, Galway.

Some of their coworkers include Brian Lesser - SVP, Commercial, Ann Howell - VP, Regulatory Affairs, and Irena Webster - VP, Development Operations. Their manager is Frank D. Lee, President & CEO.